New York [US], June 2 (ANI): Mount Sinai researchers have proven that a simple blood test called a liquid biopsy can be a stronger predictor of whether cancer immunotherapy will work for a patient with lung cancer than an invasive tumour biopsy technique.
Houston [US], May 30 (ANI): According to the University of Texas MD Anderson Cancer Center, researchers have developed an ultrasound-guided cancer immunotherapy platform that promotes systemic antitumor immunity and increases immune checkpoint blockade therapeutic efficacy.
Bengaluru (Karnataka) [India], May 28 (ANI/NewsVoir): Blood cancer has long been regarded as a death sentence. However, over the last 2 decades there has been considerable progression in the treatment of blood cancer with survival rates ranging from 60 to 80 per cent in various subtypes. On
Ney York [US], May 27 (ANI): Initial study results prove that an experimental drug called 'nemvaleukin alfa' can be used to treat several types of late-stage cancer in some patients when used alone or in combination with another anticancer drug 'pembrolizumab.'
Louisiana [US], May 9 (ANI): According to new research, scientists are working to improve immune checkpoint inhibitors to better target tumours and reduce their impact on healthy tissues.
Columbus [Ohio], April 20 (ANI): A new study has examined the differences in intratumoral immune responses between male and female cancers of non-reproductive origin.
Washington [US], April 18 (ANI): Treatments for ovarian cancer have changed little over the past few decades, with surgery and chemotherapy being the most common therapeutic approaches.
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Boston [US], February 9 (ANI): Scientists and researchers never fail to amaze us with their dedication to making breakthrough discoveries that can save life even from life-threatening diseases. In a recent study, a team of researchers from Massachusetts General Hospital (MGH) and Brigham and
Ixelles [Belgium], January 31 (ANI): In cancer research, it has been a long-known fact that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our defence against tumours. Now, a recent study has shed light on exactly "how" this happen
Washington [US], January 14 (ANI): A new study has found that the side effects of advanced cancer drugs, related to skin, indicate that they may actually be working.